Neil Robinson Selected Research

SMT C1100

1/2016	Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy.
6/2015	Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Robinson Research Topics

Disease

5	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2020 - 06/2015
2	Hypoxia (Hypoxemia) 08/2017 - 04/2016
1	COVID-19 01/2021
1	Inflammation (Inflammations) 05/2016
1	Headache (Headaches) 01/2016
1	Pain (Aches) 01/2016
1	Toothache (Toothaches) 01/2016
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2015
1	Clostridium Infections 02/2015
1	Disorders of Sex Development (Intersexuality) 11/2014
1	Hyperandrogenism 11/2014

Drug/Important Bio-Agent (IBA)

5	UtrophinIBA 12/2020 - 06/2015
2	OxazolesIBA 12/2020 - 01/2020
2	ezutromidIBA 12/2020 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 08/2017 - 04/2016
2	SMT C1100IBA 01/2016 - 06/2015
1	BenzoxazolesIBA 01/2020
1	EstersIBA 01/2020
1	HepcidinsIBA 05/2016
1	IronIBA 05/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 05/2015
1	Therapeutic UsesIBA 05/2015
1	ridinilazoleIBA 02/2015
1	Biological ProductsIBA 11/2014
1	AndrogensIBA 11/2014

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 01/2021
1	Analgesia 01/2016